The Association Between Serum Prostate‐Specific Antigen and Glycemic Index, Glycemic Load, and Metformin in Individuals with Diabetes: a Cross‐sectional Analysis

Background Improving glycemic control with Metformin therapy, glycemic index (GI), and glycemic load (GL) have been protectively associated with prostate cancer risk. No studies have yet assessed the relationship between GI, GL, and Metformin on serum prostate‐specific antigen (PSA), a controversial‐yet‐widely used marker of prostate health. Methods A cross‐section analysis of baseline PSA data from men with type 2 diabetes mellitus (T2DM) …